Hematologic effects of antimicrobials: focus on the oxazolidinone linezolid.
Kuter
D J
DJ
Department of Hematology and Oncology, Massachusetts General Hospital, Harvard Medical School, Boston 02114, USA. kuter.david@mgh.harvard.edu
Tillotson
G S
GS
D000081:Acetamides / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D000368:Aged; D000369:Aged, 80 and over; D000740:Anemia / Q000139:chemically induced; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy; D006402:Hematologic Diseases / Q000139:chemically induced*; D006801:Humans; D000069349:Linezolid; D008297:Male; D008875:Middle Aged; D009503:Neutropenia / Q000139:chemically induced; D023303:Oxazolidinones / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D019338:Polypharmacy; D011358:Product Surveillance, Postmarketing; D018570:Risk Assessment; D013921:Thrombocytopenia / Q000139:chemically induced; D013997:Time Factors
D000081:Acetamides; D000890:Anti-Infective Agents; D023303:Oxazolidinones; D000069349:Linezolid